Cochrane Special Collection: Brain tumour diagnosis and management

Cochrane Special Collection | 17 March 2021| Brain tumour diagnosis and management

This Special Collection provides up-to-date evidence in these key clinical priority areas of brain tumour research. It includes Cochrane Reviews that address several areas identified by the Neuro-Oncology James Lind Alliance Priority Setting Partnership in the UK as important to the brain tumour community. In addition to reviews included in this Special Collection, Cochrane Gynaecological, Neuro-oncology and Orphan Cancers has published a protocol on ‘Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma’.[1] The reviews in this Collection provide evidence towards clinical priority areas for research, and their funding, and therefore, are important for consumers, clinicians, healthcare providers and funders.

Brain tumour diagnosis and management

See also:

Cochrane [blog post] Diagnosing and treating brain tumours: reflections on the latest Cochrane evidence

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s